Antunes

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antunes

Quick Facts

Property Description
Active Ingredient Tamsulosin Hydrochloride
Form Oral Modified-Release Capsule or Tablet
Pharmacological Class Selective Alpha Blocker (alpha1A and alpha1D Antagonist)
General Purpose Relieving symptoms related to urinary resistance
Origin Synthetic, Sulfonamide Derivative

Antunes is a medication primarily defined by its active component, Tamsulosin Hydrochloride, and its function as a prescription-only single-ingredient drug. Tamsulosin is classified as an alpha blocker (or adrenergic alpha-antagonist), working to modulate the function of smooth muscles in the lower urinary tract.


What Type of Medicine is Antunes and What is its Composition?

Antunes is a synthetic substance, chemically a hydrochloride salt of Tamsulosin, derived from a sulfonamide chemical structure. The pharmacological classification of Tamsulosin Hydrochloride is an alpha-1 adrenoceptor antagonist. This highly selective nature is a defining characteristic, differentiating it from older agents. Tamsulosin preferentially targets the alpha1A and alpha1D receptor subtypes, focusing the therapeutic effect on the urinary system. This targeted action minimizes certain generalized effects associated with less-selective alpha blockers.


Understanding the Drug Form: Modified-Release Capsule

The physical presentation of Antunes is for oral administration, typically as a modified-release or prolonged-release capsule or tablet. This formulation is engineered using specialized pharmaceutical excipients to control the rate of active substance liberation. Tamsulosin is available as a modified-release product for once-daily dosing. This advanced delivery system ensures a steady absorption of Tamsulosin Hydrochloride over a full 24-hour period, which supports its intended once-daily dosing regimen.


What is the General Purpose of an Alpha Blocker?

The overarching purpose of Antunes is to alleviate functional symptoms related to obstruction in the urinary outflow tract. The drug works by binding to and blocking the alpha-1 receptors, which subsequently induces the relaxation of smooth muscles in the prostate gland and the neck of the bladder. The drug is used to improve urinary flow by reducing the resistance encountered during urination. This action supports the passage of urine, providing relief from obstructive urinary difficulties.

What side effects are possible with Antunes?

Official Safety Profile and Adverse Reactions

The safety profile for Antunes (Tamsulosin) is formally classified by government regulatory authorities, such as the FDA and EMA, based on the frequency of observed events. These classifications organize documented adverse reactions by system-organ-class (SOC) and categorize them from very common to very rare.

Commonly Documented Adverse Reactions

The most frequent effects, classified as common (ge 1/100 to <1/10), include Dizziness, Headache, Rhinitis, and issues related to the reproductive system, such as Abnormal ejaculation (including ejaculation failure).

Uncommon and Rare Effects

Reactions classified as uncommon (ge 1/1,000 to <1/100) include Orthostatic hypotension (a drop in blood pressure upon standing), Palpitations, gastrointestinal effects like Nausea, Diarrhea, and skin reactions such as Rash and Urticaria. Serious adverse reactions, classified as rare or very rare, include Syncope (fainting), Angioedema (swelling), Priapism (a persistent, painful erection), and Stevens-Johnson Syndrome.


Special Risks and Safety Constraints

The official labeling highlights specific risks relevant to certain contexts. Due to its alpha-blocking action, orthostatic symptoms like dizziness are detected more frequently, particularly at the initiation of therapy. A serious surgical complication, Intraoperative Floppy Iris Syndrome (IFIS), has been observed during cataract and glaucoma surgery in patients currently or previously treated with tamsulosin. This information must be conveyed to the surgeon.

Regulatory documents also state that the drug has not been studied in patients with severe hepatic impairment, and the presence of prostate carcinoma must be ruled out prior to starting and during treatment. The medication is contraindicated in individuals with a known hypersensitivity to tamsulosin, particularly if prior reactions included angioedema.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation on the overdose profile for Antunes (Tamsulosin) centers on the risk of severe cardiovascular events due to its alpha-blocking action.

Documented Overdose Presentations

The most serious documented outcome of Tamsulosin overdose is severe hypotension (critically low blood pressure), which can lead to syncope (fainting). Other manifestations reported in overdose situations include an increased heart rate (tachycardia), as well as gastrointestinal effects such as vomiting and diarrhea. Due to its modified-release formulation, the signs of an overdose may be delayed or prolonged.

Required Emergency Action

In the event of a suspected overdosage, immediate medical attention is required, and a Poison Control Center should be contacted for urgent advice. Emergency services must be called if the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened, as these are signs of a severe, life-threatening situation.

Supportive Management

No specific antidote for Tamsulosin overdose is known. Management focuses entirely on cardiovascular support, beginning with positioning the patient to restore blood pressure. If this is insufficient, the official guidance states that volume expanders (intravenous fluids) and, if necessary, vasopressors may be used. Measures such as gastric lavage and administration of activated charcoal may be employed to impede further absorption. Renal function monitoring is a necessary component of general supportive care.

Therapeutic Uses of Antunes

Therapeutic Indications and Clinical Uses

Antunes is a pharmacological agent primarily utilized in the management of specific respiratory conditions and allergic manifestations. Its clinical application focuses on stabilizing the physiological response to environmental and systemic triggers that affect the airways and mucous membranes.

Principal Applications

  • Management of Allergic Rhinitis: Antunes is frequently employed to alleviate symptoms associated with both seasonal and perennial allergic rhinitis. This includes the reduction of nasal congestion, sneezing, and pruritus (itching) of the nasal passages.
  • Control of Chronic Urticaria: The medication is indicated for the treatment of chronic idiopathic urticaria, helping to manage the development of wheals and associated skin irritation.
  • Symptomatic Relief of Allergic Conjunctivitis: It is used to address ocular symptoms of allergies, such as redness, watering, and itching of the eyes.

Mechanisms of Action and Physiological Benefits

The primary benefit of Antunes lies in its ability to modulate the body's inflammatory response. By targeting specific receptors, the medication prevents the cascade of symptoms typically triggered by allergen exposure.

  • Airway Stability: For patients with underlying respiratory sensitivities, Antunes helps maintain clearer pathways by reducing the inflammatory swelling of the mucosal lining.
  • Consistency in Symptom Control: One of the key benefits observed is the sustained stabilization of mast cells or histamine pathways, which provides a predictable level of relief from persistent allergic triggers.
  • Quality of Life Improvement: By mitigating the physical distractions of allergic symptoms—such as persistent sneezing or skin discomfort—the medication supports improved daily functioning and rest patterns.

Regulatory References

  1. NIH MedlinePlus overview on Tamsulosin

Eligibility and Restrictions for Use

Who can and cannot use Antunes?

Antunes (Tamsulosin) eligibility is strictly defined by regulatory documents, limiting its use to adult males for the symptomatic management of Benign Prostatic Hyperplasia (BPH).

The medicine is contraindicated and must not be used by several populations. These include individuals with known hypersensitivity to tamsulosin or any component, patients with a history of orthostatic hypotension, and patients diagnosed with severe hepatic insufficiency or impairment.

Use is not indicated for women, including during pregnancy or lactation, as the drug is intended exclusively for male patients. It is also not indicated for the pediatric population; safety and efficacy have not been established in children and adolescents under 18 years of age.

Regulators mandate conditional use in specific populations. Caution is required for patients with severe renal impairment (creatinine clearance < 10 ml/min), as this group has not been studied. Additionally, initiating therapy is not recommended for patients scheduled for cataract or glaucoma surgery. Prior to treatment, the presence of other conditions, such as prostate cancer, must be excluded.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Antunes (Tamsulosin Hydrochloride) is structured by its metabolism via specific liver enzymes and its action as an alpha-1 blocker. All interaction statements are derived from official regulatory documents.


Contraindicated Combinations

Co-administration is officially contraindicated with other alpha adrenergic blocking agents due to the potential for enhanced blood pressure lowering effects. It is also contraindicated to combine Antunes with strong CYP3A4 inhibitors (such as ketoconazole), as this results in a significant increase in Tamsulosin exposure (AUC and Cmax).


Pharmacokinetic and Pharmacodynamic Interactions

Interaction Type Interacting Agent Examples Official Outcome Description
Metabolic (Pharmacokinetic) Strong CYP2D6 Inhibitors (e.g., paroxetine), Strong CYP3A4 Inhibitors (e.g., ketoconazole) Increases plasma exposure of Tamsulosin; requires caution with moderate inhibitors.
Additive (Pharmacodynamic) PDE5 Inhibitors (e.g., sildenafil, tadalafil) Potential for symptomatic hypotension due to combined vasodilatory effects.
Other Cimetidine, Furosemide Cimetidine increases plasma concentration; Furosemide slightly reduces AUC and Cmax (no dose adjustment usually required).

Administration Requirement

To ensure consistent exposure, the regulatory label specifies that Antunes must be taken approximately thirty minutes following the same meal each day. The effect of food intake is documented to alter the absorption kinetics, making this timing rule mandatory.

Population-Specific Notes

Official labeling identifies patients who are CYP2D6 Poor Metabolizers as being subject to increased Tamsulosin exposure. Severe hepatic and severe renal impairment (<10 mL/min) are also listed as interaction-related cautions in some regulatory documents.

Mechanism of Action

Selective Blockade of Urinary Tract Receptors

Antunes acts as a competitive antagonist, engaging with the alpha1 A and alpha1 D adrenoceptors found in the smooth muscle of the prostate gland and bladder neck. By blocking these receptors, the drug prevents the binding of the endogenous transmitter Norepinephrine, which naturally triggers muscle contraction. This interaction prevents the cascade of molecular events that leads to muscle contraction in the lower urinary tract.

Modulation of Smooth Muscle Tension

The molecular blockade results in the inhibition of the Gq/11 signaling cascade, leading to reduced intracellular calcium flux within the target muscle cells. This core cellular event facilitates a change in the contractile state of the smooth muscle tissue in the prostate and bladder neck. This mechanism addresses only the dynamic component of resistance, modulating the physical impedance to flow without affecting the structural size of the tissue.

Dosage and Administration Information

How to Use Antunes: Official Administration Guidelines

Antunes, containing Tamsulosin Hydrochloride, is an oral medication with specific administration requirements to ensure proper use and consistent drug release. The available dosage form is typically a 0.4 mg modified-release capsule or tablet, designed for once-daily dosing.


Administration Details

Property Instruction
Route of Administration Oral
Standard Daily Dose 0.4 mg once daily. May be increased to a maximum of 0.8 mg once daily after 2 to 4 weeks if response is insufficient.
Timing and Food Administered approximately 30 minutes following the same meal each day for consistent absorption.
Physical Handling The capsule or tablet must be swallowed whole. It must not be crushed, chewed, or opened.
Interruption Rule If use is interrupted for several days, therapy must be re-started at the initial 0.4 mg once-daily dose.

Use in Specific Populations

No dosage adjustment is required for patients with CrCl ≥ 10 mL/min (renal impairment) or for those with mild to moderate hepatic impairment. Antunes is not indicated for use in pediatric patients (under 18 years of age).

These instructions define the high-level, standardized approach to using the medicine. The structure emphasizes the importance of consistent daily timing with food and the required whole-swallowing of the modified-release formulation.

Recent Clinical Evidence

Recent Clinical Evidence

Summary of Clinical Research

This section summarizes key research studies have evaluated whether the drug could improve clinical outcomes in adults with newly diagnosed multiple myeloma.

Research examined whether the drug, when used in combination with standard treatments (like dexamethasone), evaluated the potential for a reduction in disease progression among patients newly diagnosed with multiple myeloma. Studies varied in their design, including randomized controlled trials (RCTs) and long-term follow-up studies.

Results were noted in the first few weeks of some studies.


Key Study Findings and Focus Areas

Combination Therapy

The drug is often researched as an option alongside other anti-cancer agents. Its use in combination was evaluated in studies focusing on overall survival and disease progression-free survival.

  • Overall Survival: One large randomized study compared a triple-drug combination containing this drug to a two-drug regimen. The study documented differences in overall survival rates between the combination and control groups.

  • Progression-Free Survival (PFS): The same study examined the time until disease progression or death. The study compared PFS between the combination group and the control group.

Monotherapy

Some earlier research explored the drug as a single-agent treatment. These studies primarily focused on patients who had previously failed to respond to other treatments. The data described observations in this pre-treated patient population.

Comparative Effectiveness

The combination therapy was compared to single-agent therapy in research, which also collected data to assess patient quality of life.


Safety and Tolerability Profile

Clinical trials examined the drug's safety profile, focusing on frequently occurring adverse events.

Frequently Asked Questions (FAQ)

Common questions about Antunes (FAQ)

Q: How is Antunes different from older medicines used for the same thing?

A: Antunes (Tamsulosin) is classified as a selective alpha-1 adrenoceptor antagonist. Regulatory documents state that this selective action is described as focusing the effect on the prostate and bladder neck, differentiating it from less-selective agents used for similar symptoms.

Q: How quickly do people typically start to feel the effects of Antunes?

A: Studies and official information indicate that the drug reaches steady-state concentrations in the body about five days after starting once-a-day dosing. Clinical trials demonstrated improvement in symptoms associated with the condition by approximately four weeks of treatment.

Q: Is it common to have an upset stomach when starting Antunes?

A: According to the official product information, gastrointestinal effects such as nausea and diarrhea were reported in clinical trials. These effects were reported in a small percentage of patients (less than 5% for each effect) and are not considered one of the most common adverse reactions.

Q: Are there any specific foods or drinks that should be avoided while taking Antunes?

A: Regulatory guidance states that alcohol may increase the drug’s potential to lower blood pressure, which might lead to dizziness or fainting. No specific foods are restricted beyond the general requirement to take the dose 30 minutes after the same meal each day.

Q: Does Antunes require any regular lab tests or monitoring?

A: Regulatory documents require that prostate carcinoma (prostate cancer) be ruled out prior to starting and during treatment. This requirement is in place because the conditions can share similar symptoms. No routine lab monitoring for kidney or liver function is specifically mandated in the official prescribing information for non-impaired patients.

Q: Can Antunes affect performance on a driver's test?

A: Regulatory documents state that patients should be aware of the potential for side effects such as dizziness, vertigo, or syncope (fainting). Patients should avoid driving or performing hazardous tasks until they know how the medication affects them.

Q: Is Antunes safe to take long-term?

A: Official clinical studies have examined the long-term use of Antunes, and published data is available that addresses overall safety and effectiveness for men using the medication for extended periods.

Q: Can people with kidney issues use Antunes?

A: Official regulatory documents indicate that dose adjustments are not necessary for patients with a creatinine clearance ( CrCl) of 10 mL/min or greater. However, the drug has not been studied in patients with end-stage renal disease ( CrCl < 10 mL/min).

Q: Is it true that Antunes is a newer kind of drug?

A: The drug is classified as a selective alpha-1 blocker. Official product information describes its mechanism as differentiating it from older, less-selective alpha-adrenergic blocking agents.

Q: Can people with heart conditions typically use Antunes?

A: Due to its mechanism, the medication has the potential to cause a drop in blood pressure, known as symptomatic hypotension, or dizziness. Caution is noted in regulatory documents, especially when Antunes is used along with other drugs that cause vasodilation, such as PDE5 inhibitors (e.g., sildenafil).

Q: What is the expected outcome of taking Antunes according to clinical trials?

A: According to official clinical studies, Antunes is intended to manage and improve symptoms of the lower urinary tract. Studies demonstrated an increase in maximum urinary flow rate and improvement in overall symptom scores associated with the condition.

Q: Does Antunes have a generic version available?

A: Yes, the active ingredient in Antunes, tamsulosin hydrochloride, is available in the United States under multiple generic labels following approval from the FDA (ANDA Approvals).

Q: Can Antunes cause difficulty sleeping?

A: Official adverse reaction tables list insomnia (difficulty falling asleep or staying asleep) and somnolence (drowsiness) as adverse events reported in clinical trials, though typically at a low incidence.

Q: Does Antunes interact with common over-the-counter pain relievers?

A: The official label does not specifically mention interactions with common pain relievers like ibuprofen or acetaminophen. However, regulatory documents advise caution with co-administration of warfarin (a blood thinner) due to potential pharmacokinetic interactions.

Q: Is Antunes safe for older adults (seniors)?

A: Official regulatory documents indicate that no overall differences in the safety or efficacy of Antunes were observed between older and younger patients in clinical trials. However, the official guidance notes that a greater sensitivity to the drug in some older adults cannot be ruled out.

Q: Does Antunes cause changes in weight?

A: Weight changes, such as weight loss, have been observed as adverse events in post-marketing reports or clinical trials. This is generally classified as an uncommon or rare effect.

Q: Can Antunes make you feel tired or drowsy during the day?

A: According to the official adverse reaction tables, somnolence (drowsiness) is listed as an adverse event reported in clinical trials, although it is not considered one of the most common effects.

Q: Are there any known issues with taking Antunes and alcohol?

A: Regulatory guidance states that the combination of alcohol with this medication can lower blood pressure, potentially causing dizziness or fainting.

Q: Is the purpose of Antunes to cure or manage the condition?

A: The official product information states that the medication is indicated for the treatment of the signs and symptoms of the condition. It is not indicated as a cure.

Q: How long does Antunes stay in the body after the last use?

A: Pharmacokinetic data in the official product label indicate that the apparent elimination half-life of the modified-release formulation in the target patient population is typically between 14 to 15 hours.

Q: Can Antunes affect mood or anxiety levels?

A: While mood or anxiety issues are not listed as side effects, adverse events that affect a person’s mental state, such as insomnia (difficulty sleeping) and somnolence (drowsiness), are reported in official clinical trial data.

Q: Does Antunes interact with common herbal remedies like St. John's Wort?

A: Regulatory documents state that Antunes interacts with inhibitors of the CYP3A4 enzyme, such as strong CYP3A4 inhibitors. Official guidance advises caution with any concomitant use that could alter the drug’s metabolism.

Q: Is a metallic taste in the mouth a known side effect of Antunes?

A: While not listed as a common effect in official adverse reaction tables, abnormal taste has been reported as an adverse event during post-marketing surveillance or clinical trials with the active ingredient.

Q: What should be done if a potential side effect of Antunes is observed?

A: Official patient information states that medical attention is necessary if symptoms of orthostatic hypotension are recurrent or bothersome. Furthermore, serious side effects, such as priapism (a persistent, painful erection), require immediate medical attention.

Q: Can I take Antunes if I am sensitive to certain dyes or fillers?

A: Official regulatory documents state that the drug is contraindicated (must not be used) in patients with a known hypersensitivity to the active ingredient or any component of the capsules.

Q: Does Antunes have a Black Box Warning listed by the FDA?

A: The official FDA prescribing information for the active ingredient, Tamsulosin, does not carry a Black Box Warning (also known as a Boxed Warning).

Q: Is the dosage for Antunes adjusted based on a person's body weight?

A: According to the official prescribing information, dosing for Antunes is not adjusted based on a person's body weight. Any dose increase is typically based on an insufficient response to the initial dose.

How should Antunes be stored and disposed of?

Storage and Disposal Requirements

Antunes (Tamsulosin Hydrochloride) must be stored and disposed of according to specific regulatory guidelines to maintain its stability and ensure safety.


Official Storage Conditions

The medicine must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be protected from moisture and excess heat. It is mandatory to keep the medication in its original container and maintain the container tightly closed.

Child Safety and Disposal

For safety, Antunes must be stored out of the sight and reach of children.

Expired or unused medication must not be disposed of via wastewater or household garbage. It should be returned to a pharmacist or utilized in an approved local drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antunes found in:

A-Z Index: